Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver
- 15 July 1993
- Vol. 72 (2) , 375-380
- https://doi.org/10.1002/1097-0142(19930715)72:2<375::aid-cncr2820720211>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasmsCancer, 1991
- Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolizationCancer, 1991
- Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumorsCancer, 1990
- A Phase II Trial of Streptozotocin and Adriamycin in Advanced APUD TumorsAmerican Journal of Clinical Oncology, 1988
- Treatment of Hepatic Metastases in Ocular MelanomaPublished by American Medical Association (AMA) ,1986
- Hepatic Arterial Streptozocin: A Clinical Pharmacologic Study in Patients with Liver TumorsCancer Drug Delivery, 1983